Alvine Pharmaceuticals, Inc., a biopharmaceutical company focused on the treatment of autoimmune and gastrointestinal diseases, today announced that the first randomized study patient was dosed in the CeliAction Study™
Accelerating diagnosis, treatments, and a cure for celiac disease and non-celiac gluten sensitivity through research, education, and advocacy.
Kathy Giusti, CEO of the Multiple Myeloma Research Foundation (MMRF). Marilyn Geller, CEO of the Celiac Disease Foundation (CDF). What do these women have in common? They are leading dynamic, nonprofit organizations that are driving innovation, awareness and research in diseases once relatively unknown or incurable-and they’re all coming at it from a personal connection. […]